Home oxygen therapy after preterm birth in Western Australia

Journal of Paediatrics and Child Health
A SalettiK Simmer

Abstract

To review our management of infants discharged home receiving supplemental oxygen. Stable preterm infants receive low flow O(2) by nasal cannulae aiming for SaO(2) of > or = 95%. Oxygen-dependent infants must pass an air test (ability to maintain SaO(2) > 80% during 4 h disconnection from oxygen) before discharge home with supplemental oxygen. A sleep study is performed before nocturnal O(2) is ceased. Infants less than 33 weeks gestational age (GA) who were admitted January 1999-June 2001 and discharged home with supplemental oxygen were identified through the databases and medical records of the King Edward Memorial/Princess Margaret Hospitals. The data collected were compared with an audit performed a decade earlier. Ninety-three infants were discharged home with supplemental oxygen between 1999 and 2001 (10% neonatal intensive care unit admissions less than 33 weeks GA; median GA 26 weeks (interquartile range 25-28). All infants had an air test before discharge: 63% failed the first air test and 30% at least two air tests. The median delay between the first air test and discharge was 2 weeks. The median postmenstrual age at discharge was 40 weeks gestation (interquartile range 38-41). Ninety infants had a sleep study before...Continue Reading

References

Nov 1, 1992·The American Review of Respiratory Disease·C L MarcusS L Ward
Jun 1, 1995·Journal of Paediatrics and Child Health·D T SilvaP D Sly
Apr 1, 1995·Journal of Paediatrics and Child Health·J K Chye, P H Gray
Aug 1, 1993·Journal of Paediatrics and Child Health·I B Masters, M I Asher
Aug 1, 1996·Respiration Physiology·K A WatersI R Moss
Mar 1, 1997·Archives of Disease in Childhood. Fetal and Neonatal Edition·R Iles, A T Edmunds
Dec 10, 1997·European Journal of Pediatrics·E BaraldiF Zacchello
May 7, 1998·BMJ : British Medical Journal·V Hughes
Nov 12, 1998·Pediatric Pulmonology·D FitzgeraldC Sullivan
Apr 2, 1999·Pediatrics·L CharafeddineD L Phelps
Jun 1, 2000·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·D G Sweet, H L Halliday
Jun 13, 2001·American Journal of Respiratory and Critical Care Medicine·A H Jobe, E Bancalari
Jul 31, 2003·American Journal of Respiratory and Critical Care Medicine·Julian AllenUNKNOWN American Thoracic Society
Sep 5, 2003·The New England Journal of Medicine·Lisa Maree AskieJudy Margaret Simpson

❮ Previous
Next ❯

Citations

Feb 22, 2012·Clinics in Perinatology·Máximo VentoMarta Aguar
Sep 16, 2004·Journal of Paediatrics and Child Health·M K Lal, S Sinha
Oct 18, 2016·Pediatric Pulmonology·Jennifer YehJoseph M Collaco
Jul 1, 2017·Journal of Korean Medical Science·Ji Sook KimUNKNOWN Committee on Data Collection and Statistical Analysis, the Korean Society of Neonatology
Jan 13, 2018·Annals of the American Thoracic Society·Joseph M Collaco, Sharon A McGrath-Morrow
Jun 9, 2020·Respirology : Official Journal of the Asian Pacific Society of Respirology·Nitin KapurDominic A Fitzgerald
Dec 11, 2019·Therapeutic Advances in Respiratory Disease·Sharon A McGrath-Morrow, Joseph M Collaco
Aug 29, 2020·International Journal of Molecular Sciences·Shih-Hsin Wang, Po-Nien Tsao
Mar 29, 2019·ERJ Open Research·Natalie BateyJayesh Mahendra Bhatt
Feb 24, 2021·Pediatric Pulmonology·Matthew D WongJasneek Chawla
Dec 15, 2020·Paediatric Respiratory Reviews·Lucy H EverittHazel J Evans
Oct 22, 2021·BMJ : British Medical Journal·Margaret GilfillanVineet Bhandari

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.